메뉴 건너뛰기




Volumn 96, Issue 2, 2013, Pages 198-204

Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: Prospective trial in once-daily versus twice-daily tacrolimus

Author keywords

Biopsy proven acute rejection; Kidney transplantation; Pharmacokinetics; Prolonged release tacrolimus

Indexed keywords

TACROLIMUS;

EID: 84880571525     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318296c9d5     Document Type: Article
Times cited : (41)

References (24)
  • 1
    • 34247238869 scopus 로고    scopus 로고
    • Kidney and pancreas transplantation in the United States, 1996Y2005
    • Andreoni KA, Brayman KL, Guidinger MK, et al. Kidney and pancreas transplantation in the United States, 1996Y2005. Am J Transplant 2007; 7: 1359.
    • (2007) Am J Transplant , vol.7 , pp. 1359
    • Andreoni, K.A.1    Brayman, K.L.2    Guidinger, M.K.3
  • 2
    • 10844292763 scopus 로고    scopus 로고
    • Immunosuppressive drugs for kidney transplantation
    • Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715.
    • (2004) N Engl J Med , vol.351 , pp. 2715
    • Halloran, P.F.1
  • 3
    • 0024419167 scopus 로고
    • FK 506 for liver, kidney, and pancreas transplantation
    • Starzl TE, Todo S, Fung J, et al. FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989; 2: 1000.
    • (1989) Lancet , vol.2 , pp. 1000
    • Starzl, T.E.1    Todo, S.2    Fung, J.3
  • 4
    • 26644469263 scopus 로고    scopus 로고
    • Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data
    • Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 2005; 331: 810.
    • (2005) BMJ , vol.331 , pp. 810
    • Webster, A.C.1    Woodroffe, R.C.2    Taylor, R.S.3
  • 5
    • 0037006627 scopus 로고    scopus 로고
    • Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study
    • Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359: 741.
    • (2002) Lancet , vol.359 , pp. 741
    • Margreiter, R.1
  • 6
    • 0035081018 scopus 로고    scopus 로고
    • A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation
    • Sperschneider H. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. Transplant Proc 2001; 33: 1279.
    • (2001) Transplant Proc , vol.33 , pp. 1279
    • Sperschneider, H.1
  • 7
    • 37349034394 scopus 로고    scopus 로고
    • Reduced exposure to calcineurin inhibitors in renal transplantation
    • Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
    • (2007) N Engl J Med , vol.357 , pp. 2562
    • Ekberg, H.1    Tedesco-Silva, H.2    Demirbas, A.3
  • 8
    • 0025168461 scopus 로고
    • The effect of prescribed daily dose frequency on patient medication compliance
    • Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881.
    • (1990) Arch Intern Med , vol.150 , pp. 1881
    • Eisen, S.A.1    Miller, D.K.2    Woodward, R.S.3
  • 9
    • 1642327515 scopus 로고    scopus 로고
    • Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review
    • Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769.
    • (2004) Transplantation , vol.77 , pp. 769
    • Butler, J.A.1    Roderick, P.2    Mullee, M.3
  • 10
    • 78649896434 scopus 로고    scopus 로고
    • Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study
    • Kramer BK, Charpentier B, Backman L, et al. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant 2010; 10: 2632.
    • (2010) Am J Transplant , vol.10 , pp. 2632
    • Kramer, B.K.1    Charpentier, B.2    Backman, L.3
  • 11
    • 70350125161 scopus 로고    scopus 로고
    • Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial
    • Wlodarczyk Z, Squifflet JP, Ostrowski M, et al. Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. Am J Transplant 2009; 9: 2505.
    • (2009) Am J Transplant , vol.9 , pp. 2505
    • Wlodarczyk, Z.1    Squifflet, J.P.2    Ostrowski, M.3
  • 12
    • 57349120571 scopus 로고    scopus 로고
    • Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats
    • Mitamura T, Yamada A, Hanaoka K, et al. Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats. J Toxicol Sci 2008; 33: 575.
    • (2008) J Toxicol Sci , vol.33 , pp. 575
    • Mitamura, T.1    Yamada, A.2    Hanaoka, K.3
  • 13
    • 33847758317 scopus 로고    scopus 로고
    • One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/ MMF in de novo kidney transplant recipients
    • Silva HT Jr, Yang HC, Abouljoud M, et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/ MMF in de novo kidney transplant recipients. Am J Transplant 2007; 7: 595.
    • (2007) Am J Transplant , vol.7 , pp. 595
    • Silva Jr., H.T.1    Yang, H.C.2    Abouljoud, M.3
  • 14
    • 77957205275 scopus 로고    scopus 로고
    • Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation
    • Trunecka P, Boillot O, Seehofer D, et al. Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. Am J Transplant 2010; 10: 2313.
    • (2010) Am J Transplant , vol.10 , pp. 2313
    • Trunecka, P.1    Boillot, O.2    Seehofer, D.3
  • 15
    • 0033609074 scopus 로고    scopus 로고
    • Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: Results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8)
    • Grant D, Kneteman N, Tchervenkov J, et al. Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8). Transplantation 1999; 67: 1133.
    • (1999) Transplantation , vol.67 , pp. 1133
    • Grant, D.1    Kneteman, N.2    Tchervenkov, J.3
  • 16
    • 84862806052 scopus 로고    scopus 로고
    • Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial
    • Wlodarczyk Z, Ostrowski M, Mourad M, et al. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial. Ther Drug Monit 2012; 34: 143.
    • (2012) Ther Drug Monit , vol.34 , pp. 143
    • Wlodarczyk, Z.1    Ostrowski, M.2    Mourad, M.3
  • 17
    • 0032855982 scopus 로고    scopus 로고
    • Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients
    • Bottiger Y, Brattstrom C, Tyden G, et al. Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients. Br J Clin Pharmacol 1999; 48: 445.
    • (1999) Br J Clin Pharmacol , vol.48 , pp. 445
    • Bottiger, Y.1    Brattstrom, C.2    Tyden, G.3
  • 19
    • 0035080534 scopus 로고    scopus 로고
    • Experimental study of tacrolimus immunosuppression on the mode of administration: Efficacy of constant intravenous infusion avoiding C(max)
    • Ishibashi M, Yoshida K, Ozono S, et al. Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max). Transplant Proc 2001; 33: 559.
    • (2001) Transplant Proc , vol.33 , pp. 559
    • Ishibashi, M.1    Yoshida, K.2    Ozono, S.3
  • 20
    • 77952594383 scopus 로고    scopus 로고
    • Once daily tacrolimus formulation: Monitoring of plasma levels, graft function, and cardiovascular risk factors
    • Mecule A, Poli L, Nofroni I, et al. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. Transplant Proc 2010; 42: 1317.
    • (2010) Transplant Proc , vol.42 , pp. 1317
    • Mecule, A.1    Poli, L.2    Nofroni, I.3
  • 21
    • 84872956718 scopus 로고    scopus 로고
    • Improved adherence to tacrolimus once-daily formulation in renal recipients: A randomized controlled trial using electronicmonitoring
    • Kuypers DR, Peeters PC, Sennesael JJ, et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronicmonitoring. Transplantation 2013; 95: 333.
    • (2013) Transplantation , vol.95 , pp. 333
    • Kuypers, D.R.1    Peeters, P.C.2    Sennesael, J.J.3
  • 22
    • 0036842816 scopus 로고    scopus 로고
    • Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients
    • Hesse CJ, Baan CC, Balk AH, et al. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients. Transplant Proc 2002; 34: 2988.
    • (2002) Transplant Proc , vol.34 , pp. 2988
    • Hesse, C.J.1    Baan, C.C.2    Balk, A.H.3
  • 23
    • 6344257079 scopus 로고    scopus 로고
    • The EMIT 2000 tacrolimus assay: An application protocol for the Beckman Synchron LX20 PRO analyzer
    • LeGatt DF, Shalapay CE, Cheng SB. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer. Clin Biochem 2004; 37: 1022
    • (2004) Clin Biochem , vol.37 , pp. 1022
    • Legatt, D.F.1    Shalapay, C.E.2    Cheng, S.B.3
  • 24
    • 77955588938 scopus 로고    scopus 로고
    • Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients
    • Bazin C, Guinedor A, Barau C, et al. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients. J Pharm Biomed Anal 2010; 53: 997. Sciences
    • (2010) J Pharm Biomed Anal , vol.53 , pp. 997
    • Bazin, C.1    Guinedor, A.2    Barau, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.